Uterine Sarcoma Clinical Trial
Official title:
A Randomized Double-blind Phase II Study Evaluating the Role of Maintenance Therapy With Cabozantinib in High Grade Uterine Sarcoma (HGUtS) After Stabilization or Response to Doxorubicin +/- Ifosfamide Following Surgery or in Metastatic First Line Treatment
This study aims to investigate a drug called Cabozantinib which belongs to a family of drugs that have effects on tumour growth, blood supply, invasion and spread. Therefore, we want to find out whether taking cabozantinib after treatment with surgery and chemotherapy is effective and safe for patients who responded or had stable disease after their chemotherapy. All participants will receive 4-6 cycles of standard chemotherapy. Those with stabilization or response to the standard chemotherapy will be split into 2 groups (cabozantinib or placebo).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
Recruiting |
NCT00162721 -
The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas
|
Phase 3 | |
Completed |
NCT01806350 -
Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors
|
N/A | |
Recruiting |
NCT05881967 -
Molecular Mechanism Study of Uterine Sarcoma
|
||
Active, not recruiting |
NCT06244251 -
Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids
|
N/A | |
Completed |
NCT00020267 -
Vaccine Therapy in Treating Patients With Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT04224467 -
The Application of Real-Time Near-infrared Imaging in Gynecological Surgery
|
N/A | |
Completed |
NCT01303094 -
Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma
|
Phase 2 | |
Available |
NCT03493165 -
Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)
|